FDA commissioner to depart

Laura Pedulli | | Health Exec | Management

After six years on the job, FDA Commissioner Margaret Hamburg, MD, is stepping down, reports Clinical Innovation + Technology.

Under her tenure, Hamburg has overseen public health initiatives ranging from tobacco control and food safety to personalized medicine, disease control and drug approvals.

Read more below:

FDA Commissioner stepping down

Laura Pedulli

Related Content

Hospital and police department feud over baggie of drugs in patient’s rectum
Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers
FDA issues Class I recall on counterfeit infusion pump batteries
FDA issues alert on PCNL sheath safety after patient death
Bipartisan bills in Congress would force insurance companies, PBMs to sell pharmacies
Anthem BCBS reverses course on anesthesia time limits

Around the web

Cardiovascular Business
Stryker acquires Inari Medical for $4.9B

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Radiology Business
Policies and regulations shaping radiology in 2025

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year.